Loading...
Raloxifene. Not better than estrogen.
Raloxifene is marketed in France for prevention of nontraumatic vertebral fracture in postmenopausal women. In animal pharmacology studies, it was found to both agonize and antagonize estrogen. The assessment file is methodologically sound but fails to answer many practical questions. A placebo-cont...
Saved in:
| Format: | Artigo |
|---|---|
| Language: | Inglês |
| Published: |
College of Family Physicians of Canada
2000
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2144789/ https://ncbi.nlm.nih.gov/pubmed/10955178 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|